US$ 20.93
gala semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s WEGOVY 0.5MG(SEMAGLUTIDE INJECTION ) X
Description
Robinson N, Bergen SE

Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base (2025)

[(accessed on 5 April 2024)]

This results in a low intrinsic risk of hypoglycaemia, though this risk increases when used alongside insulin or sulfonylureas (dose adjustments of these medications may be needed)

Serious Side Effects Less common but more serious side effects can include acute pancreatitis (severe abdominal pain that does not resolve), acute gallbladder disease (upper stomach pain, jaundice, fever), acute kidney injury (often related to dehydration from GI side effects), serious allergic reactions, hypoglycemia (especially if taking other diabetes medications), and mental health changes including suicidal thoughts

Others take a few minutes
